|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
She K, Yan H, Huang J, Zhou H and He J:
miR-193b availability is antagonized by LncRNA-SNHG7 for
FAIM2-induced tumour progression in non-small cell lung cancer.
Cell Prolif:. 51:2018. View Article : Google Scholar
|
|
4
|
Yang J, Zhao H, Xin Y and Fan L:
MicroRNA-198 inhibits proliferation and induces apoptosis of lung
cancer cells via targeting FGFR1. J Cell Biochem. 115:987–995.
2014. View Article : Google Scholar
|
|
5
|
Kohler J: Second-line treatment of
NSCLC-the Pan-ErbB inhibitor afatinib in times of shifting
paradigms. Front Med (Lausanne). 4:92017.
|
|
6
|
Patel RA, Liu Y, Wang B, Li R and Sebti
SM: Identification of novel ROCK inhibitors with anti-migratory and
anti-invasive activities. Oncogene. 33:550–555. 2014. View Article : Google Scholar :
|
|
7
|
Vigil D, Kim TY, Plachco A, Garton AJ,
Castaldo L, Pachter JA, Dong H, Chen X, Tokar B, Campbell SL and
Der CJ: ROCK1 and ROCK2 are required for non-small cell lung cancer
anchorage-independent growth and invasion. Cancer Res.
72:5338–5347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rath N and Olson MF: Rho-associated
kinases in tumorigenesis: Re-considering ROCK inhibition for cancer
therapy. EMBO Rep. 13:900–908. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu S, Guo X, Gao X, Xue H, Zhang J, Guo X,
Qiu W, Zhang P and Li G: Macrophage migration inhibitory factor
enhances autophagy by regulating ROCK1 activity and contributes to
the escape of dendritic cell surveillance in glioblastoma. Int J
Oncol. 49:2105–2115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang GX, Wang Y, Su J, Zhou P, Li B, Yin
LJ and Lu J: Up-regulation of Rho-associated kinase 1/2 by
glucocorticoids promotes migration, invasion and metastasis of
melanoma. Cancer Lett. 410:1–11. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Z, Wang Z, Liu J and Yang H: Long
non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis
of osteosarcoma by targeting ROCK1. Biomed Pharmacother.
107:598–605. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhan Y, Zheng N, Teng F, Bao L, Liu F,
Zhang M, Guo M, Guo W, Ding G and Wang Q: MiR-199a/b-5p inhibits
hepatocellular carcinoma progression by post-transcriptionally
suppressing ROCK1. Oncotarget. 8:67169–67180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Croft DR, Sahai E, Mavria G, Li S, Tsai J,
Lee WM, Marshall CJ and Olson MF: Conditional ROCK activation in
vivo induces tumor cell dissemination and angiogenesis. Cancer Res.
64:8994–9001. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng Y, Chen Z, Chen Y, Li S, Jiang Y,
Yang H, Wu C, You F, Zheng C, Zhu J, et al: ROCK isoforms
differentially modulate cancer cell motility by mechanosensing the
substrate stiffness. Acta Biomater. 88:86–101. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao J and Guan JL: Signal transduction by
focal adhesion kinase in cancer. Cancer Metastasis Rev. 28:35–49.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu W, Liang Y, Chan Q, Jiang L and Dong
J: CX3CL1 promotes lung cancer cell migration and invasion via the
Src/focal adhesion kinase signaling pathway. Oncol Rep.
41:1911–1917. 2019.PubMed/NCBI
|
|
17
|
Gates RE, King LE Jr, Hanks SK and Nanney
LB: Potential role for focal adhesion kinase in migrating and
proliferating keratinocytes near epidermal wounds and in culture.
Cell Growth Differ. 5:891–899. 1994.PubMed/NCBI
|
|
18
|
Azab AK, Azab F, Blotta S, Pitsillides CM,
Thompson B, Runnels JM, Roccaro AM, Ngo HT, Melhem MR, Sacco A, et
al: RhoA and Rac1 GTPases play major and differential roles in
stromal cell-derived factor-1-induced cell adhesion and chemo-taxis
in multiple myeloma. Blood. 114:619–629. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jaraiz-Rodriguez M, Tabernero MD,
Gonzalez-Tablas M, Otero A, Orfao A, Medina JM and Tabernero A: A
short region of Connexin43 reduces human glioma stem cell
migration, invasion, and survival through Src, PTEN, and FAK. Stem
Cell Reports. 9:451–463. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang LL, Liu J, Lei S, Zhang J, Zhou W
and Yu HG: PTEN inhibits the invasion and metastasis of gastric
cancer via down-regulation of FAK expression. Cell Signal.
26:1011–1020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tamura M, Gu J, Matsumoto K, Aota S,
Parsons R and Yamada KM: Inhibition of cell migration, spreading,
and focal adhesions by tumor suppressor PTEN. Science.
280:1614–1617. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Julian L and Olson MF: Rho-associated
coiled-coil containing kinases (ROCK): Structure, regulation, and
functions. Small GTPases. 5:e298462014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guan R, Xu X, Chen M, Hu H, Ge H, Wen S,
Zhou S and Pi R: Advances in the studies of roles of Rho/Rhokinase
in diseases and the development of its inhibitors. Eur J Med Chem.
70:613–622. 2013. View Article : Google Scholar
|
|
24
|
Fragoso R and Barata JT: Kinases, tails
and more: Regulation of PTEN function by phosphorylation. Methods.
77-78:75–81. 2015. View Article : Google Scholar
|
|
25
|
Malemud CJ: The PI3K/Akt/PTEN/mTOR
pathway: A fruitful target for inducing cell death in rheumatoid
arthritis? Future Med Chem. 7:1137–1147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang R, Li G, Zhang Q, Tang Q, Huang J,
Hu C, Liu Y, Wang Q, Liu W, Gao N and Zhou S: Hirsutine induces
mPTP-dependent apoptosis through ROCK1/PTEN/PI3K/GSK3β pathway in
human lung cancer cells. Cell Death Dis. 9:5982018. View Article : Google Scholar
|
|
27
|
Rami-Porta R, Asamura H, Travis WD and
Rusch VW: Lung cancer-major changes in the American Joint Committee
on Cancer eighth edition cancer staging manual. CA Cancer J Clin.
67:138–155. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohisto-chemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.In German. PubMed/NCBI
|
|
29
|
Shi H, Chen S, Jin H, Xu C, Dong G, Zhao
Q, Wang W, Zhang H, Lin W, Zhang J, et al: Downregulation of MSP58
inhibits growth of human colorectal cancer cells via regulation of
the cyclin D1-cyclin-dependent kinase 4-p21 pathway. Cancer Sci.
100:1585–1590. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang GH, Yao L, Xu HW, Tang WT, Fu JH, Hu
XF, Cui L and Xu XM: Identification of MXRA5 as a novel biomarker
in colorectal cancer. Oncol Lett. 5:544–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Toro-Tapia G, Villaseca S, Beyer A,
Roycroft A, Marcellini S, Mayor R and Torrejón M: The
Ric-8A/Ga13/FAK signaling cascade controls focal adhesion formation
during neural crest cell migration in Xenopus. Development.
145:pii: dev164269. 2018. View Article : Google Scholar
|
|
32
|
Liu C, Li Y, Xing Y, Cao B, Yang F, Yang
T, Ai Z, Wei Y and Jiang J: The interaction between cancer stem
cell marker CD133 and Src protein promotes focal adhesion kinase
(FAK) phosphor-ylation and cell migration. J Biol Chem.
291:15540–15550. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Matsuda S, Kawamoto K, Miyamoto K, Tsuji A
and Yuasa K: PCTK3/CDK18 regulates cell migration and adhesion by
negatively modulating FAK activity. Sci Rep. 7:455452017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang J, Li L, Peng Y, Chen Y, Lv X, Li S,
Qin X, Yang H, Wu C and Liu Y: Surface chemistry induces
mitochondria-mediated apoptosis of breast cancer cells via
PTEN/PI3K/AKT signaling pathway. Biochim Biophys Acta Mol Cell Res.
1865:172–185. 2018. View Article : Google Scholar
|
|
35
|
Alfieri R, Giovannetti E, Bonelli M and
Cavazzoni A: New treatment opportunities in phosphatase and tensin
homolog (PTEN)-deficient tumors: Focus on PTEN/Focal adhesion
kinase pathway. Front Oncol. 7:1702017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vemula S, Shi J, Hanneman P, Wei L and
Kapur R: ROCK1 functions as a suppressor of inflammatory cell
migration by regulating PTEN phosphorylation and stability. Blood.
115:1785–1796. 2010. View Article : Google Scholar :
|
|
37
|
Li GB, Cheng Q, Liu L, Zhou T, Shan CY, Hu
XY, Zhou J, Liu EH, Li P and Gao N: Mitochondrial translocation of
cofilin is required for allyl isothiocyanate-mediated cell death
via ROCK1/PTEN/PI3K signaling pathway. Cell Commun Signal.
11:502013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
André E and Becker-André M: Expression of
an N-terminally truncated form of human focal adhesion kinase in
brain. Biochem Biophys Res Commun. 190:140–147. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang J and Hochwald SN: The role of FAK
in tumor metabolism and therapy. Pharmacol Ther. 142:154–163. 2014.
View Article : Google Scholar
|
|
40
|
Schaller MD: Biochemical signals and
biological responses elicited by the focal adhesion kinase. Biochim
Biophys Acta. 1540:1–21. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Siesser PM and Hanks SK: The signaling and
biological implications of FAK overexpression in cancer. Clin
Cancer Res. 12:3233–3237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ucar DA and Hochwald SN: FAK and
interacting proteins as therapeutic targets in pancreatic cancer.
Anticancer Agents Med Chem. 10:742–746. 2010. View Article : Google Scholar
|
|
43
|
Sulzmaier FJ, Jean C and Schlaepfer DD:
FAK in cancer: Mechanistic findings and clinical applications. Nat
Rev Cancer. 14:598–610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Roycroft A, Szabó A, Bahm I, Daly L,
Charras G, Parsons M and Mayor R: Redistribution of adhesive forces
through Src/FAK drives contact inhibition of locomotion in neural
crest. Dev Cell. 45:565–579.e3. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gilkes DM, Xiang L, Lee SJ, Chaturvedi P,
Hubbi ME, Wirtz D and Semenza GL: Hypoxia-inducible factors mediate
coordinated RhoA-ROCK1 expression and signaling in breast cancer
cells. Proc Natl Acad Sci USA. 111:E384–E393. 2014. View Article : Google Scholar
|
|
46
|
Amin E, Dubey BN, Zhang SC, Gremer L,
Dvorsky R, Moll JM, Taha MS, Nagel-Steger L, Piekorz RP, Somlyo AV
and Ahmadian MR: Rho-kinase: Regulation, (dys)function, and
inhibition. Biol Chem. 394:1399–1410. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wermke M, Camgoz A, Paszkowski-Rogacz M,
Thieme S, von Bonin M, Dahl A, Platzbecker U, Theis M, Ehninger G,
Brenner S, et al: RNAi profiling of primary human AML cells
identifies ROCK1 as a therapeutic target and nominates fasudil as
an antileukemic drug. Blood. 125:3760–3768. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhu L, Wang X, Wang T, Zhu W and Zhou X:
miR-494-3p promotes the progression of endometrial cancer by
regulating the PTEN/PI3K/AKT pathway. Mol Med Rep. 19:581–588.
2019.
|
|
49
|
Wu YR, Qi HJ, Deng DF, Luo YY and Yang SL:
MicroRNA-21 promotes cell proliferation, migration, and resistance
to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal
cancer. Tumour Biol. 37:12061–12070. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Fu Q, Huang Y, Ge C, Li Z, Tian H, Li Q,
Li H, Li R, Tao X, Xue Y, et al: SHIP1 inhibits cell growth,
migration, and invasion in nonsmall cell lung cancer through the
PI3K/AKT pathway. Oncol Rep. 41:2337–2350. 2019.PubMed/NCBI
|
|
51
|
Jiang W, Cheng Y, Zhao N, Li L, Shi Y,
Zong A and Wang F: Sulfated polysaccharide of Sepiella Maindroni
ink inhibits the migration, invasion and matrix metalloproteinase-2
expression through suppressing EGFR-mediated p38/MAPK and
PI3K/Akt/mTOR signaling pathways in SKOV-3 cells. Int J Biol
Macromol. 107:349–362. 2018. View Article : Google Scholar
|
